Innovation for Disease Resistance
Focus Area: Traits
Each year, plant diseases cause an estimated 40% yield loss worldwide in the most important food crops. Our goal at Corteva Agriscience™, Agriculture Division of DowDuPont is to develop robust, sustainable and durable solutions to crop disease problems. Our strategy relies on an integrated approach to disease control: stacking native disease traits with transgenic traits; applying CRISPR-Cas genome editing technologies to accelerate development of resistant plant lines; combining genetic solutions with chemical and/or biological products for comprehensive control. We invite public and private sector scientists to join in our efforts with innovative approaches that will help tackle and find solutions to the most important global crop diseases.
This submission is now closed.
What We Are Investigating
- Novel sources of resistance for controlling economically important corn, soybean, wheat, and canola diseases
- Methods to accelerate resistance gene discovery
- Strategies to broaden or enhance resistance gene activity
- Rapid and/or high throughput methods to screen for resistance gene function
- Determination of disease resistance mechanisms and mode of action of disease resistance genes
- Resistance strategies that target critical pathogen factors or their host targets
- Biologicals for management of disease agents and nematodes
- Novel approaches to early disease detection and trait efficacy monitoring
Who Should Apply
- Plant pathologists, breeders or geneticists with interest or experience in disease resistance traits
- Scientists with expertise in mechanisms of plant disease resistance
- Molecular biologists or biochemists with expertise in R gene-mediated resistance
- Individuals with expertise and interest in applying innovative methods for monitoring plant diseases
- Any creative or innovative scientist with ideas that can be adapted to help us achieve our goals
- Institutions or organizations with related experience
For submissions received by October 1, 2017:
- We will review and evaluate your submissions within 60 days; and notify you of its status by December 1, 2017.
- An Open Innovation representative will contact selected applicants to provide further details on the grant process.
Intellectual property and publication rights will remain with the selected grant applicants
How Can We Help
- Funding (up to $50,000)
- As applicable:
- Transformation resources
- Access to next generation sequencing resources
- Molecular marker resources
- Disease testing/bioassay resources
- Opportunity for an extended collaboration and a path to market for viable concepts